Harnessing and modulating inflammation in strategies for bone regeneration.

Inflammation is an immediate response that plays a critical role in healing after fracture or injury to bone. However, in certain clinical contexts, such as in inflammatory diseases or in response to the implantation of a biomedical device, the inflammatory response may become chronic and result in destructive catabolic effects on the bone tissue. Since our previous review 3 years ago, which identified inflammatory signals critical for bone regeneration and described the inhibitory effects of anti-inflammatory agents on bone healing, a multitude of studies have been published exploring various aspects of this emerging field. In this review, we distinguish between regenerative and damaging inflammatory processes in bone, update our discussion of the effects of anti-inflammatory agents on bone healing, summarize recent in vitro and in vivo studies demonstrating how inflammation can be modulated to stimulate bone regeneration, and identify key future directions in the field.

[1]  Hiroshi Takayanagi,et al.  T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ , 2000, Nature.

[2]  Dongan Wang,et al.  In vivo and in vitro osteogenesis of stem cells induced by controlled release of drugs from microspherical scaffolds , 2010 .

[3]  M. Feldmann,et al.  TNF-α promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells , 2011, Proceedings of the National Academy of Sciences.

[4]  D. Hu,et al.  Action of IL‐1β during fracture healing , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[5]  T. Sculco,et al.  Prophylaxis of Heterotopic Ossification of the Hip: Systematic Review and Meta‐Analysis , 2009 .

[6]  Kozo Nakamura,et al.  Association of microsomal prostaglandin E synthase 1 deficiency with impaired fracture healing, but not with bone loss or osteoarthritis, in mouse models of skeletal disorders. , 2008, Arthritis and rheumatism.

[7]  S. Mckercher,et al.  Wound Healing in the PU.1 Null Mouse—Tissue Repair Is Not Dependent on Inflammatory Cells , 2003, Current Biology.

[8]  L. Nordsletten,et al.  Parecoxib and Indomethacin Delay Early Fracture Healing: A Study in Rats , 2009, Clinical orthopaedics and related research.

[9]  Per Aspenberg,et al.  Drugs and fracture repair , 2005, Acta orthopaedica.

[10]  Xin-Fu Zhou,et al.  Treating skeletal pain: limitations of conventional anti-inflammatory drugs, and anti-neurotrophic factor as a possible alternative , 2009, Nature Clinical Practice Rheumatology.

[11]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell stem cell.

[12]  A. Kaneko,et al.  Influences of anti-tumour necrosis factor agents on postoperative recovery in patients with rheumatoid arthritis , 2010, Clinical Rheumatology.

[13]  A. Reznick,et al.  Exposure to pro-inflammatory cytokines upregulates MMP-9 synthesis by mesenchymal stem cells-derived osteoprogenitors , 2008, Histochemistry and Cell Biology.

[14]  Meijing Wang,et al.  Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. , 2008, American journal of physiology. Cell physiology.

[15]  D. Magne,et al.  TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. , 2009, Life sciences.

[16]  C. Colnot,et al.  Trauma-Induced Inflammation and Fracture Healing , 2010, Journal of orthopaedic trauma.

[17]  Nimrod Rozen,et al.  Fracture repair: modulation of fracture-callus and mechanical properties by sequential application of IL-6 following PTH 1-34 or PTH 28-48. , 2007, Bone.

[18]  D. Graves,et al.  Impaired Fracture Healing in the Absence of TNF‐α Signaling: The Role of TNF‐α in Endochondral Cartilage Resorption , 2003 .

[19]  C. Bourgeault,et al.  OP-1 Augments Glucocorticoid-inhibited Fracture Healing in a Rat Fracture Model , 2009, Clinical orthopaedics and related research.

[20]  A. M. Simon,et al.  Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. , 2007, The Journal of bone and joint surgery. American volume.

[21]  E. Schwarz,et al.  Ubiquitin Ligase Smurf1 Mediates Tumor Necrosis Factor-induced Systemic Bone Loss by Promoting Proteasomal Degradation of Bone Morphogenetic Signaling Proteins* , 2008, Journal of Biological Chemistry.

[22]  E. Krall,et al.  Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment. , 2007, The Journal of bone and joint surgery. American volume.

[23]  H. Takayanagi Osteoimmunology and the effects of the immune system on bone , 2009, Nature Reviews Rheumatology.

[24]  Nona T Colburn,et al.  A role for gamma/delta T cells in a mouse model of fracture healing. , 2009, Arthritis and rheumatism.

[25]  Antonios G Mikos,et al.  Modulation of the inflammatory response for enhanced bone tissue regeneration. , 2008, Tissue engineering. Part B, Reviews.

[26]  M. Boers,et al.  Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice , 2010, Annals of the rheumatic diseases.

[27]  S. Doty,et al.  Thrombin peptide (TP508) promotes fracture repair by up‐regulating inflammatory mediators, early growth factors, and increasing angiogenesis , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[28]  L Dunn,et al.  A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery , 2000, Acta orthopaedica Scandinavica.

[29]  S A Goldstein,et al.  Osteoporosis induced in mice by overproduction of interleukin 4. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  F. Kaplan,et al.  Fibrodysplasia ossificans progressiva , 2008, Best practice & research. Clinical rheumatology.

[31]  R. Quigg,et al.  TP508 accelerates fracture repair by promoting cell growth over cell death. , 2007, Biochemical and biophysical research communications.

[32]  Thomas A Einhorn,et al.  High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing. , 2009, The American journal of pathology.

[33]  A. M. Simon,et al.  Cyclo‐Oxygenase 2 Function Is Essential for Bone Fracture Healing , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  E. Schwarz,et al.  Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. , 2009, Arthritis and rheumatism.

[35]  D. Carney,et al.  Could rusalatide acetate be the future drug of choice for diabetic foot ulcers and fracture repair? , 2008, Expert opinion on pharmacotherapy.

[36]  R. Guldberg,et al.  Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4. , 2009, The American journal of pathology.

[37]  R. Guldberg,et al.  COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healing. , 2008, Bone.

[38]  Jiro Takito,et al.  Inhibition of STAT1 accelerates bone fracture healing , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[39]  D. Macdonald,et al.  Nonunion of the femoral diaphysis , 2000 .

[40]  J. Kuiper,et al.  The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study , 2009, Journal of orthopaedic surgery and research.

[41]  Georg N Duda,et al.  Insight into the molecular pathophysiology of delayed bone healing in a sheep model. , 2010, Tissue engineering. Part A.

[42]  M. Bostrom,et al.  Systemic corticosteroids inhibit bone healing in a rabbit ulnar osteotomy model , 2000, Acta orthopaedica Scandinavica.

[43]  J. Jacobs,et al.  Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis , 2010, Nature Reviews Rheumatology.

[44]  Cory Berkland,et al.  Injectable PLGA based colloidal gels for zero-order dexamethasone release in cranial defects. , 2010, Biomaterials.

[45]  A. Caplan Why are MSCs therapeutic? New data: new insight , 2009, The Journal of pathology.

[46]  J. David,et al.  The multiple faces of autoimmune-mediated bone loss , 2010, Nature Reviews Endocrinology.

[47]  D. Hu,et al.  Rejuvenation of the inflammatory system stimulates fracture repair in aged mice , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[48]  Antonios G Mikos,et al.  Dose effect of tumor necrosis factor-alpha on in vitro osteogenic differentiation of mesenchymal stem cells on biodegradable polymeric microfiber scaffolds. , 2010, Biomaterials.

[49]  E. Gómez-Barrena,et al.  Role of the N- and C-terminal fragments of parathyroid-hormone-related protein as putative therapies to improve bone regeneration under high glucocorticoid treatment. , 2010, Tissue engineering. Part A.

[50]  Liping Tang,et al.  The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. , 2010, Biomaterials.

[51]  C. Bäckesjö,et al.  IL-6 receptor expression and IL-6 effects change during osteoblast differentiation. , 2008, Cytokine.

[52]  R. Pereira,et al.  Serum from children with polyarticular juvenile idiopathic arthritis (pJIA) inhibits differentiation, mineralization and may increase apoptosis of human osteoblasts “in vitro” , 2008, Clinical Rheumatology.

[53]  C. Krettek,et al.  Biochemical changes after trauma and skeletal surgery of the lower extremity: quantification of the operative burden. , 2000 .

[54]  T A Einhorn,et al.  Expression of Osteoprotegerin, Receptor Activator of NF‐κB Ligand (Osteoprotegerin Ligand) and Related Proinflammatory Cytokines During Fracture Healing , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[55]  N. Pleshko Camacho,et al.  Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. , 2007, Bone.

[56]  S. Vukicevic,et al.  An EP2 receptor-selective prostaglandin E2 agonist induces bone healing , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Hamilton,et al.  Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. , 2009, Osteoarthritis and cartilage.

[58]  Y. Kapila,et al.  TNF-α Promotes an Odontoblastic Phenotype in Dental Pulp Cells , 2009, Journal of dental research.

[59]  D. Solomon,et al.  Nonsteroidal antiinflammatory drugs and nonunion of humeral shaft fractures. , 2005, Arthritis and rheumatism.

[60]  S. Goodman,et al.  The Effects of Medications on Bone , 2007, The Journal of the American Academy of Orthopaedic Surgeons.

[61]  R. Landewé,et al.  Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA , 2010, Annals of the rheumatic diseases.

[62]  A R Pettit,et al.  TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. , 2001, The American journal of pathology.

[63]  C. Ohlsson,et al.  Bone formation in interleukin‐4 and interleukin‐13 depleted mice , 2008, Acta orthopaedica.

[64]  G. Duda,et al.  Cellular composition of the initial fracture hematoma compared to a muscle hematoma: A study in sheep , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[65]  K. Miyazono,et al.  Cathepsin K-Dependent Toll-Like Receptor 9 Signaling Revealed in Experimental Arthritis , 2008, Science.

[66]  T. Notomi,et al.  Nanogel-based scaffold delivery of prostaglandin E(2) receptor-specific agonist in combination with a low dose of growth factor heals critical-size bone defects in mice. , 2011, Arthritis and rheumatism.

[67]  A. Wetterwald,et al.  Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. , 2006, Bone.

[68]  J. Anglen,et al.  Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion. , 2003, The Journal of bone and joint surgery. British volume.

[69]  J. Jansen,et al.  Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo. , 2005, Journal of biomedical materials research. Part A.

[70]  Subburaman Mohan,et al.  Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. , 2006, Bone.

[71]  D. Docheva,et al.  IKK-2 is required for TNF-α-induced invasion and proliferation of human mesenchymal stem cells , 2008, Journal of Molecular Medicine.

[72]  J. Parvizi,et al.  Nonsteroidal anti-inflammatory drugs in orthopaedics. , 2009, The Journal of bone and joint surgery. American volume.

[73]  M. Kotoula,et al.  Parecoxib has non-significant long-term effects on bone healing in rats when administered for a short period after fracture , 2008, Archives of Orthopaedic and Trauma Surgery.

[74]  T. Einhorn,et al.  Impaired Intramembranous Bone Formation during Bone Repair in the Absence of Tumor Necrosis Factor-Alpha Signaling , 2001, Cells Tissues Organs.

[75]  J. Cottrell,et al.  Pharmacological inhibition of 5-lipoxygenase accelerates and enhances fracture-healing. , 2009, The Journal of bone and joint surgery. American volume.

[76]  G. Stein,et al.  Enhanced fracture repair by leukotriene antagonism is characterized by increased chondrocyte proliferation and early bone formation: A novel role of the cysteinyl LT‐1 receptor , 2009, Journal of cellular physiology.

[77]  Y. Toyama,et al.  Fra‐1/AP‐1 Impairs Inflammatory Responses and Chondrogenesis in Fracture Healing , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[78]  J. Kinney,et al.  Repair of rabbit segmental defects with the thrombin peptide, TP508 , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[79]  Thomas A Einhorn,et al.  Differential Temporal Expression of Members of the Transforming Growth Factor β Superfamily During Murine Fracture Healing , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[80]  Kristi S Anseth,et al.  Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNFalpha. , 2009, Biomaterials.

[81]  Y. Iwakura,et al.  IL-1 plays an important role in the bone metabolism under physiological conditions. , 2010, International immunology.

[82]  M. Dougados,et al.  Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. , 2007, Clinical and experimental rheumatology.

[83]  J. Cottrell,et al.  Effect of Non-Steroidal Anti-Inflammatory Drugs on Bone Healing , 2010, Pharmaceuticals.

[84]  Toshitaka Nakamura,et al.  Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. , 2004, Bone.

[85]  A. Wymenga,et al.  Risk Factors for Surgical Site Infections and Other Complications in Elective Surgery in Patients with Rheumatoid Arthritis with Special Attention for Anti-Tumor Necrosis Factor: A Large Retrospective Study , 2008 .

[86]  Hong Zhou,et al.  Osteoblast-targeted disruption of glucocorticoid signalling does not delay intramembranous bone healing , 2010, Steroids.

[87]  A. Ivković,et al.  Autologous bone grafting on steroids: preliminary clinical results. A novel treatment for nonunions and segmental bone defects , 2011, International Orthopaedics.

[88]  G. Stein,et al.  Arachidonic Acid, Eicosanoids, and Fracture Repair , 2010, Journal of orthopaedic trauma.

[89]  E. Schwarz,et al.  EP1−/− Mice Have Enhanced Osteoblast Differentiation and Accelerated Fracture Repair , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[90]  K. Ikari,et al.  Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-alpha blockers: perioperative interruption of tumour necrosis factor-alpha blockers decreases complications? , 2010, Rheumatology.

[91]  G. Duda,et al.  Fracture healing is accelerated in the absence of the adaptive immune system , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[92]  R. Reis,et al.  Ex vivo culturing of stromal cells with dexamethasone-loaded carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles promotes ectopic bone formation. , 2010, Bone.

[93]  G. Lyritis,et al.  Effect of cortisone and an anabolic steroid upon plasma hydroxyproline during fracture healing in rabbits. , 1975, Acta orthopaedica Scandinavica.

[94]  J. O'Connor,et al.  Accelerated fracture healing in mice lacking the 5-lipoxygenase gene , 2010, Acta orthopaedica.

[95]  Li Sun,et al.  Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation , 2006, Proceedings of the National Academy of Sciences.

[96]  J. Capo,et al.  A comparison of the effects of ibuprofen and rofecoxib on rabbit fibula osteotomy healing , 2009, Acta orthopaedica.

[97]  M. Endres,et al.  Immunomodulation of tissue-engineered transplants: in vivo bone generation from methylprednisolone-stimulated chondrocytes , 2004, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[98]  U. Ritz,et al.  Cell viability, osteoblast differentiation, and gene expression are altered in human osteoblasts from hypertrophic fracture non-unions. , 2008, Bone.

[99]  J. Magaziner,et al.  Persistent changes in interleukin-6 and lower extremity function following hip fracture. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[100]  G. Duda,et al.  The early fracture hematoma and its potential role in fracture healing. , 2010, Tissue engineering. Part B, Reviews.

[101]  H. Pieringer,et al.  Patients with rheumatoid arthritis undergoing surgery: how should we deal with antirheumatic treatment? , 2007, Seminars in arthritis and rheumatism.

[102]  T. Wirth,et al.  TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. , 2009, Bone.